I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Dahl, Nathan A.
139
results:
Search for persons
X
Format
Online (139)
Mediatypes
Articles (Online) (85)
Bookchapter (Online) (2)
OpenAccess-fulltext (52)
Sorted by: Relevance
Sorted by: Year
?
1
HGG-41. COMBINATORIAL BH3-MIMETIC STRATEGY FOR OVERCOMING R..:
Madhavan, Krishna
;
Donthula, Sahiti
;
Walker, Faye M
...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024
Link:
https://doi.org/10.1093/..
?
2
IDH-mutant astrocytoma arising from a demyelinating plaque ..:
Kalter, Joshua A
;
Yang, Ronald A
;
Toland, Angus
...
Journal of Neuropathology & Experimental Neurology. 83 (2024) 4 - p. 289-292 , 2024
Link:
https://doi.org/10.1093/..
?
3
ETMR-31. A UNIQUE CASE OF CNS DIFFUSE, NON-SYSTEMIC ALK+ HI..:
DeMarsh, Samantha J
;
Orr, Brent
;
Willard, Nicholas
.
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024
Link:
https://doi.org/10.1093/..
?
4
NFS-30. ADJUVANT MEK INHIBITION TO PREVENT REBOUND GROWTH F..:
Chan, Priya P
;
Hemenway, Molly S
;
Sabus, Ashley
...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024
Link:
https://doi.org/10.1093/..
?
5
MDB-88. DUAL TARGETING OF PROCESSIVE TRANSCRIPTION FOR MYC-..:
Walker, Faye M
;
Madhavan, Krishna
;
Sobral, Lays Martin
...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024
Link:
https://doi.org/10.1093/..
?
6
CP-12. PHASE 0 AND FEASIBILITY SINGLE-INSTITUTION CLINICAL ..:
Dorris, Kathleen
;
Mettetal, Ashley
;
Hemenway, Molly
...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024
Link:
https://doi.org/10.1093/..
?
7
ATRT-07. PRC1/BMI1 ACTIVITY ALTERS CHROMATIN ACCESSIBILITY ..:
Alimova, Irina
;
Murdock, Gillian
;
Pierce, Angela M
...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024
Link:
https://doi.org/10.1093/..
?
8
Rapid P-TEFb-dependent transcriptional reorganization under..:
Walker, Faye M.
;
Sobral, Lays Martin
;
Danis, Etienne
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
9
XRT-06. RAPID PTEFB-DEPENDENT TRANSCRIPTIONAL REORGANIZATIO..:
Walker, Faye
;
Sobral, Lays Martin
;
Danis, Etienne
...
Neuro-Oncology. 25 (2023) Supplement_1 - p. i78-i78 , 2023
Link:
https://doi.org/10.1093/..
?
10
Thromboembolic toxicity observed with concurrent trametinib..:
Chan, Priya P.
;
Sabus, Ashley
;
Hemenway, Molly S.
...
Pediatric Blood & Cancer. 70 (2023) 3 - p. , 2023
Link:
https://doi.org/10.1002/..
?
11
MDB-37. CDK9 IS A DRUGGABLE MEDIATOR SUSTAINING MYC-DRIVEN ..:
Krishna, Madhavan
;
Walker, Faye
;
Sobral, Lays Martin
...
Neuro-Oncology. 25 (2023) Supplement_1 - p. i70-i70 , 2023
Link:
https://doi.org/10.1093/..
?
12
PDGFB:APOBEC3C fusion in congenital diffuse high-grade glio..:
Norris, Gregory A
;
Willard, Nicholas
;
Donson, Andrew M
...
Journal of Neuropathology & Experimental Neurology. 82 (2023) 2 - p. 183-186 , 2023
Link:
https://doi.org/10.1093/..
?
13
HGG-17. Novel Fusion in Congenital Brainstem Diffuse High-G..:
Norris, Gregory
;
Donson, Andrew
;
Milgrom, Sarah
...
Neuro-Oncology. 24 (2022) Supplement_1 - p. i64-i64 , 2022
Link:
https://doi.org/10.1093/..
?
14
MEDB-28. CDK9 is a druggable mediator sustaining Myc-driven..:
Madhavan, Krishna
;
Walker, Faye
;
Wang, Dong
...
Neuro-Oncology. 24 (2022) Supplement_1 - p. i111-i111 , 2022
Link:
https://doi.org/10.1093/..
?
15
RARE-32. Phase 0 and feasibility single-institution clinica..:
Dorris, Kathleen
;
Mettetal, Ashley
;
Dahl, Nathan
...
Neuro-Oncology. 24 (2022) Supplement_1 - p. i17-i17 , 2022
Link:
https://doi.org/10.1093/..
1-15